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A randomised clinical trial was conducted to explore the effect of orally supplementedmedium-chain
fatty acids (MCFA) to heifers and cows starting 6–8 weeks prior to expected calving date on blood
and milk polymorphonuclear neutrophilic leucocyte (PMNL) apoptosis between 1 and 3 d in milk
(DIM). The effects of MCFA-supplementation on the likelihood of intramammary infections (IMI)
in early lactation, and test-day somatic cell count (SCC) and average daily milk yield (MY) during
the first 4 months of lactation were evaluated as well. Twenty-two animals were included of
which half were orally supplemented with MCFA starting 6–8 weeks prior to calving and half
served as non-supplemented controls. The PMNL viability in both blood and milk was quantified
using dual-colour flow cytometry with fluorescein-labelled annexin and propidium iodide. In
non-supplemented animals, % blood PMNL apoptosis significantly increased between start of
supplementation and early lactation, reflecting a potential reduction in innate immune capacity,
whereas this was not true in the MCFA-supplemented animals. Similar results were seen in milk
PMNL apoptosis. Overall, the % apoptotic milk PMNL between 1 and 3 DIM was significantly lower
in the MCFA-supplemented group compared with the non-supplemented group. There was no
substantial effect of oral MCFA-supplementation on the likelihood of quarter IMI nor on the
composite test-day milk SCC or average daily MY. In conclusion, oral MCFA-supplementation
starting 6–8 weeks before expected calving date supported the blood and milk neutrophil viability
in early lactating dairy cows. Still, this was not reflected in an improvement of udder health nor
MY in early and later lactation. The results should trigger research to further unravel the mechanisms
behind the observed immunomodulating effect, and the potential relevance for the cows’
performances throughout lactation.
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The dry period is known as the most crucial yet ambivalent
period for udder health in a cow’s lactation cycle. The steady
state involution phase offers an excellent opportunity for
curing existing intramammary infections (IMI) whereas the
active involution phase and colostrogenesis are conversely
periods of high risk for contracting new IMI at the same time
(Bradley & Green, 2010). The incidence rate of IMI during
the dry period is up to 10-times higher than the rate of IMI
during lactation with a peak around involution of the
mammary gland just after drying off and during the transition
from pregnancy to lactation (Smith et al. 1985).
The high incidence of infectious diseases in early lactation
in dairy cows such as clinical mastitis, has been directly
linked to the impaired functionality of blood and milk
polymorphonuclear neutrophilic leucocytes (PMNLs) at that
time as compared with mid and late lactation (Mehrzad et al.
2001; Van Oostveldt et al. 2001, 2002). The pathways of
this immunosuppression have yet not been fully unravelled
although studies both in vitro and in vivo indicate that the
oxidative stress cows undergo during transition is a major
underlying factor (Bernabucci et al. 2005; Castillo et al.
2005; Sordillo &Aitken, 2009). Stimulating or supporting the
cellular immune function of periparturient dairy cows could
potentially help them in meeting their challenges during this
critical period around calving.
In human medicine, there is increasing evidence that
medium-chain fatty acids (MCFA) have strong antioxidant
properties, delaying or even preventing cell and tissue
damage from oxidative stress (Henry et al. 2002; Lemieux
et al. 2011). MCFA are naturally present in coconut oil, palm*For correspondence; e-mail: Sofie.Piepers@UGent.be
Journal of Dairy Research, Page 1 of 10 © Proprietors of Journal of Dairy Research 2013
doi:10.1017/S0022029913000228
1
kernel oil and camphor tree drupes (Breckenridge & Kuksis,
1967). Although a plethora of information is available on
the immunomodulating effects of MCFA in humans (e.g.
Bellinati-Pires et al. 1993; Wanten et al. 2002; Versleijen
et al. 2005) only little is known about these effects in the
bovine.
Hence the main objective of this study was to explore the
effect of orally supplemented MCFA to heifers and cows
starting 6–8 weeks prior to expected calving date on blood
and milk PMNL functionality in early lactation. In addition,
the effect of MCFA-supplementation on the likelihood of IMI
in early lactation, and on the evolution of test-day somatic
cell count (SCC) andmilk yield (MY) during the first 4months
of lactation was evaluated. The findings could be helpful in
generating new hypotheses on improving mammary gland
immunity or udder health around calving through nutrition
and give indications for future research.
Materials and Methods
The study was approved by the ethical committee of the
Faculty of Veterinary Medicine, Ghent University (EC 2008/
137).
Herd
A randomised blind clinical trial was conducted from June
2009 to June 2010 on the research dairy farm of Ghent
University (Biocentrum Agri-Vet, Melle, Belgium) equipped
with a free-stall barn with saw-dusted cubicles and a
Voluntary Milking System (VMS, DeLaval, Tumba,
Sweden). The herd consisted of approximately 50 lactating
Black Holstein-Friesian cows at the time the trial was
conducted. Mean 305-d production was 9565 kg. Average
bulk milk SCC during the study period was 266000 cells/ml.
Both pregnant heifers and dry cows had access to pasture
between June and October, and were kept indoors between
October and June. In the period the heifers were kept
indoors, they were fed grass silage, corn silage and hay.
Additionally, 150 g/d of a commercial mineral/vitamin mix
containing vitamin E, Se, magnesium, zinc and copper was
fed (Prolacta®, AVEVE, Belgium). Dry cows were daily fed
25 kg of corn silage, 0·5 kg of protein supplements, hay ad
libitum and 200 g of a commercial dry cow mineral/vitamin
mix containing vitamin E, Se, magnesium, zinc and copper
(Prolacta®, AVEVE, Belgium). At dry-off, broad-spectrum
long-acting antibiotics were introduced in each quarter
[Virbactan (ex. Cobactan D.C.), VIRBAC Animal Health,
Leuven, Belgium]. Both heifers and cows were introduced to
the group of lactating cows approximately 2 weeks before
expected calving date. A couple of days before calving, the
animals were moved to box stalls bedded with straw.
Study design
On the farm, a cohort of twelve conveniently selected
(i.e. based on the expected calving date) end-term
second lactation cows and 10 end-term heifers were
blocked by parity, alternately assigned to either the
control (n=11) or the MCFA (supplemented) group (n=11)
at dry-off and 45 d before the expected calving date,
respectively. All animals were clinically healthy at the
moment of inclusion. Heifers and cows with general signs
of disease or with signs of clinical mastitis [any abnormal
aspect of the milk (flakes, clots, and a watery or other
unusual appearance) whether or not in combination
with other visible abnormalities of the udder (redness,
swelling, . . .)] between selection and calving were excluded
from the study and replaced by the animal within the
same parity block that was closest to dry-off. One cow
belonging to the MCFA-supplemented group was
excluded and replaced for this reason because she
suffered from a severe case of clinical mastitis 5 d before
calving. Both the control and supplemented group even-
tually consisted of 5 heifers and 6 multiparous cows. A
trial period for an individual animal lasted approximately
160–190 d, encompassing either the entire dry period
(average 52 d) for multiparous cows or 38–66 d before
calving (average 53 d) for heifers, and the first 4 months
of the subsequent lactation. Daily oral supplementation of
25 g of a mix of MCFA (concentration active substance
500mg/g) (Aromabiotic Cattle®, Nuscience, Drongen)
per animal started at dry-off for multiparous cows and
7 weeks prior to expected calving date for end-term
heifers and continued up to 4 months in lactation. The
dose was chosen based on the manufacturers’ prescriptions.
All animals calved between September 2009 and March
2010.
Sample collection
Blood samples. Six to eight weeks before expected calving
date and between 1 and 3 DIM (referred to as early lactation
throughout the paper), blood samples (30 ml) were collected
from the tail vein using EDTA vacutainer tubes (Terumo,
Leuven, Belgium) to determine blood PMNL viability of all
22 animals. After collection, the blood samples were mixed
with 30ml Alsever’s solution as anticoagulant in a 60-ml
syringe for further processing.
Milk samples. Milk samples were obtained from the multi-
parous cows at dry-off and early lactation (colostral
phase), and in early lactation only for the heifers at the
same time of blood sampling. Firstly, duplicate quarter milk
samples for bacteriological culturing were aseptically
collected before milking after the first three streams of
milk were discarded. Subsequently, single quarter milk
samples were collected for determination of the milk
PMNL viability (100 ml) and somatic cell count (SCC)
(30 ml). Twenty-five ml and 10ml milk of each quarter was
transferred into one tube in order to obtain a composite milk
sample for determination of the PMNL viability and SCC,
respectively.
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Intramammary infection status
Bacteriological culturing. The intramammary infection
status was determined based on bacteriological culturing.
Bacteriological culturing and isolate identification of milk
was done as previously described (Piepers et al. 2007).
A milk sample was considered culture-positive when growth
of 54 colonies was detected, except for quarters infected
with Staphylococcus aureus or Streptococcus agalactiae
which were considered as culture-positive when growth
of 51 colony was detected. Samples yielding colonies
of 53 different bacterial species were considered to be
contaminated. The plates were incubated aerobically at
37 °C and examined at 24 and 48 h.
Definition of intramammary infection status. The IMI-status
was defined at the quarter level as previously described by
Pantoja et al. (2009). A quarter was considered infected
when the same mastitis pathogen was isolated from both
duplicate milk samples. Isolation of a mastitis pathogen
from only one of the duplicate milk samples was considered
non-significant growth classifying a quarter as non-infected.
When one of the duplicate samples was contaminated but
no organisms were recovered from the other sample the
quarter was considered to be non-infected. When both
duplicate milk samples were contaminated the data were
considered missing.
Blood and milk neutrophil apoptosis
Isolation and identification of blood and milk neutrophils.
Blood and milk PMNL were isolated and identified as
described by Piepers et al. (2009a). Briefly, isolation of blood
leucocytes was performed by centrifugation (300 g), removal
of plasma and buffy coat, hypotonic lysis of erythrocytes,
and two washing steps (Mehrzad et al. 2002). The final
volume of composite milk (100ml) was divided equally
over four 50-ml Falcon tubes, diluted 50% vol/vol with cold
phosphate-buffered saline (PBS), and centrifuged (300 g)
at 4 °C for 15min (Piepers et al. 2009a). After carefully re-
moving the cream layer, the pellet was resuspended, centri-
fuged, and washed two more times (Mehrzad et al. 2002).
Blood PMNL were discriminated from other blood cells
based on their size and internal complexity in a forward-side
scatter dot plot (FSC-SSC dot-plot) (Van Oostveldt et al.
2001). For milk, a two-step fluorescent immunolabelling
using a primary anti-bovine monoclonal granulocyte anti-
body (CH138A) (VMRD Inc., Pullman WA, USA) and an
Alexa 647-labelled goat anti-mouse IgM secondary antibody
(Molecular Probes, Leiden, TheNetherlands) was conducted
(Piepers et al. 2009a). Milk PMNL were differentiated from
other milk cells based on their cytoplasmatic granularity and
mean fluorescence intensity. Cell debris was gated out sett-
ing an optimised threshold of 10000 based on the forward-
scatter properties in the FSC-SSC dot-plot. Milk PMNL were
eventually identified using the SSC vs. Alexa 647 dot-plot
by drawing a gating region to enclose the PMNL based on
the cytoplasmic granularity and CH138A positivity as pre-
viously described (Piepers et al. 2009a). Recordings of
scatter and fluorescent properties were performed on 10000
gated events. Results were corrected for autofluorescence
which was defined as the fluorescence associated with non-
labelled freshly isolated milk PMNL of the same cow.
Quantification of blood and milk neutrophil apoptosis.
Apoptotic PMNL were identified using a double fluorescent
isothiocyanate (FITC)-annexin-V and propidium iodide (PI)
staining (Van Oostveldt et al. 2001; Piepers et al. 2009a). As
apoptosis does not occur in circulation (Van Oostveldt et al.
1999a) spontaneous apoptosis in blood was induced by
incubating the isolated blood PMNL for 18 h at 37 °C before
PMNL viability was determined. PMNLs that were positive
for FITC and negative for PI were considered as (early)
apoptotic, whereas PMNL that were positive for both FITC
and PI were considered as necrotic (Vermes et al. 1995;
Van Oostveldt et al. 2001; Piepers et al. 2009a). PMNLs that
were negative for both FITC and PI were considered as
viable. Both the viable and necrotic subpopulation was
excluded from the analysis. All analyses were performed on
a double-laser, bench-top flow cytometer (BD FacsCanto II)
and processed using FACSDiva Software (Becton Dickinson,
Belgium). The data were described as mean±SEM. For the
statistical analysis, a square-root transformation of the %
of apoptotic blood and milk PMNL was used to normalise
the data.
Test-day somatic cell count and milk yield
Composite milk SCC and MY (kg milk/d) at test-day for the
first 4 recordings (on average up till 137 DIM) were available
per animal on a four-weekly basis as part of the DHI
programme. Milk SCCwas quantified by electronic counting
(Fossomatc 5000™, Foss Electric, Hillerød, Denmark) at the
Milk Control Centre, Flanders (Lier, Belgium). The data were
described as mean±SEM. For the statistical analysis, a natural
logarithmic transformation of the test-day SCC (LnSCC) was
performed to obtain a normal distribution.
Statistical analyses
Prior to statistical analysis, all observations were explored
and checked for unlikely values. No data were excluded for
this reason. A square-root transformation of the % apoptotic
PMNL (both blood and milk) and a natural logarithmic trans-
formation of SCC (LnSCC) were performed to normalise the
data.
Several (mixed) regression models (1) to (4) were fitted to
determine the association between the supplementation
status of the animals (supplemented vs. non-supplemented
control) and the % PMNL apoptosis, the likelihood of IMI
in early lactation and the test-day SCC and MY during the
first 4 months of lactation, respectively, using SAS 9.3
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(SAS Institute Inc., Cary NC, USA) unless otherwise
mentioned.
Yij ¼ β0 þ β1 Suppþ β2Perþ β3Parþ μCowð jÞ þ eij; ð1Þ
where Y is the observed value for either the % apoptotic
blood or milk PMNL and where μCow( j ) is the repeated effect
of the cow i (i=1 to 22) containing the jth observation ( j=1
or 2), and eij is the random error term;
Yi ¼ β0 þ β1Suppþ β2Par; ð2Þ
with Y being the observed value for the % apoptotic milk
PMNL in early lactation (1–3 DIM) of cow i (i=1 to 22). This
model was fitted in MLwiN 2·02 (Centre for Multilevel
Modelling, Bristol, UK);
Yij ¼ β0 þ β1 Suppþ β2 Testþ β3 Parþ μCowðjÞ þ eij; ð3Þ
where Y is the observed value for the test-day SCC andMY at
the jth observation, respectively, and where μCow(j) is the
repeated effect of the cow i (i=1–22) containing the jth
observation ( j=1–4), and eij is the random error term;
Logit Yij
  ¼ β0 þ β1Suppþ β2Parþ μCowð jÞ þ eij;
where Yij is the probability of the jth quarter within the
ith animal having IMI in early lactation (1 and 3 DIM), and
eij is the random error term. This model was fitted in MLwiN
2.02 (Centre for Multilevel Modelling, Bristol, UK).
In all models, β0 is the intercept (overall mean), β1 to β3
are the regression coefficients of the different fixed effects
included as categorical predictor variables [Supp=the
fixed effect of the MCFA-supplementation status of the
animals (two levels; supplementation vs. no supplemen-
tation), Per=the fixed effect of the period in which the
observation was obtained (two levels; at dry-off vs. early
lactation), Test=the fixed effect of test-day (five levels;
15–45 DIM, 46–75 DIM, 76–125 DIM, 126–155 DIM,
156–185 DIM) at which the SCC and MY were determined,
and Par=the fixed effect of the parity of the animals (two
levels; heifers vs. multiparous cows)]. The model with the
outcome variable test-day MY was further adjusted for
LnSCC at test-day by including it as an additional predictor
variable. In the mixed regression models (1) and (3), com-
pound symmetry covariance structures were used to model
the autocorrelation in the residual error in the repeated
measures of the response variables. The goodness of fit
measures for the mixed regression models included 2 log-
likelihood (2LL), Akaike’s information criterion (AIC),
and Bayesian information criterion (BIC). Significance was
assessed at P40·05. A backwards stepwise reduction
was performed to obtain the final model. In all models, all
first-order interactions were tested and removed when
non-significant (P>0·05).
Results
Intramammary infection in early lactation
In general, 31·2% of the quarters were infected at
dry-off. Coagulase-negative staphylococci (CNS) and
Corynebacterium bovis accounted for 73·3 and 26·7% of
the infections, respectively. None of the quarters was infec-
ted with Staphylococcus aureus, Streptococcus uberis,
Streptococcus agalactiae, Streptococcus dysgalactiae or
Gram-negative bacteria. In early lactation 20·5% (n=70) of
all quarters was infected with CNS accounting for 83·3%
(n=15). Staph. aureus and Str. uberiswere isolated from one
and two quarters, respectively. Odds of IMI (all pathogens)
among animals in early lactation was not significantly differ-
ent between multiparous cows and heifers (OR: 0·2; 95% CI
0·04, 1·3).
The effect of MCFA-supplementation starting at dry-off on
the likelihood of IMI was evaluated on 48 duplicate quarter
milk samples collected from multiparous cows at dry-off
and on 88 duplicate quarter milk samples collected from
both heifers and multiparous cows in early lactation. Odds
of IMI (all pathogens) among animals in early lactation was
not significantly different between supplemented and non-
supplemented animals (OR: 2·15; 95%CI: 0·4, 12·8). During
the first month of lactation, 2 control animals contracted
each one case of clinical mastitis.
Blood and milk neutrophil apoptosis
Blood neutrophil apoptosis. The % apoptotic blood
PMNL at 6–8 weeks before calving was 14·1±1·5% (range
4·4–37·1%) and increased to 26·4±2·6% (range 7·7–45·3%)
in early lactation. The % apoptotic blood PMNL was sig-
nificantly higher in multiparous cows (22·9±3·1%) com-
pared with heifers (17·1±3·7%) (P<0·05). At the beginning
of supplementation,%blood PMNL apoptosis was not differ-
ent between the control and supplemented animals (Fig. 1).
Blood PMNL apoptosis in the control group increased
from 13·1±1·4% at dry-off to 33·1±3·5% in early lactation
(Fig. 1). Control animals had a significantly higher % blood
PMNL apoptosis in early lactation (33·1±3·5%) than supple-
mented animals (19·7±2·4%) (Fig. 1). In the supplemented
animals, % apoptotic blood PMNL remained more or less
stable between start of supplementation (15·2±2·7%) and
early lactation (19·7±2·4%) (Fig. 1).
Milk neutrophil apoptosis. Post-partum milk PMNL apopto-
sis was more pronounced in multiparous cows (49·8±5·3%)
than in heifers (34·4±3·4%) (P<0·01). No association was
found between the quarter IMI-status and milk PMNL
apoptosis. At dry-off, milk PMNL apoptosis in multiparous
cows did not differ between the control (43·1±4·0%) and
MCFA supplemented group (37·7±4·2%). Still, in control
animals % apoptotic milk PMNL increased throughout the
dry period from 43·1±4·0% at dry-off to 61·5±5·4% in early
lactation whereas in supplemented animals milk PMNL
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apoptosis remained stable throughout the dry period (from
37·7±4·2% to 38·0±4·3%) (Fig. 2). Milk PMNL apoptosis in
early lactationwashigher innon-supplemented (51·6±4·9%)
than in MCFA-supplemented animals (33·9±3·1%) in both
heifers and multiparous cows (P<0·001) (Fig. 3).
Test-day somatic cell count and milk yield
Test-day SCC decreased from 419091±84633 cells/ml in
early lactation (1 and 3 DIM) to 125636±68792 cells/ml
at first test-day and then again gradually increased to
241045±109753 cells/ml at the 4th test-day. Multiparous
cows had higher test-day SCC compared with heifers and
the increase in test-day SCC over time was more pro-
nounced in multiparous cows than in heifers (P-value for
parity×DIM <0·05) (Fig. 4).
Average daily MY increased from 37·4±1·5 kg/d at first
test-day to 40·7±1·6 kg/d at second test-day and then
gradually decreased to 37·5±1·1 kg/d at last test-day of the
trial. Multiparous cows started at a much higher daily
MY than heifers, but the increase in daily MY to peak
production at first test-day was less pronounced (Fig. 5).
Test-day LnSCC was negatively associated with the average
daily MY at test-day.
Supplementation was not associated with test-day SCC
(P=0·34) although a slightly higher test-day SCC was
observed in the MCFA-supplemented multiparous cows
compared with the non-supplemented multiparous cows, in
particular at 2 months after calving (P=0·14; Fig. 4). No
overall effect of MCFA-supplementation on average daily
MY was observed (P=0·45) although a tendency for a higher
average daily MY at second test-day was seen in multiparous
cows (P=0·06; Fig. 5).
Discussion
The work reported here was set out to explore the effect
of oral supplementation of a commercially available mix of
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Fig. 1. (a) Back-transformed least square means of % apoptotic blood polymorphonuclear neutrophilic leucocytes (PMNLs) in both control
(■) and MCFA-supplemented ( ) animals between the start of supplementation (6–8 weeks before expected calving date) and early lactation
[1–3 d in milk (DIM)]. Significant pairwise differences (P<0·05) within and between treatment groups are indicated by a and b, respectively.
In control animals, % apoptotic blood PMNLs (5 heifers and 6 multiparous cows) was significantly higher in early lactation than at dry-off.
Control animals had a significantly higher % apoptotic blood in early lactation compared to the MCFA-supplemented animals (5 heifers
and 6 multiparous cows). (B) Representative flow cytometric analysis of blood PMNLs with a dual colour Annexin-V-fluorescein (FITC) and
propidium iodide staining in control and MCFA-supplemented animals between the start of supplementation (6–8 weeks before expected
calving date) and early lactation [1–3 d in milk (DIM)]. The percentage of negative (=viable), single positive (apoptotic) and double positive
(=necrotic) PMNLs is shown in the individual quadrants.
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MCFA to heifers and multiparous cows starting at 6–8 weeks
prior to calving on PMNL apoptosis and udder health in
early lactation as well as on udder health and MY in the
first months of lactation in a small-scale, randomised blind
clinical trial. Neutrophil apoptosis was determined both in
blood and milk using an innovative and accurate flow
cytometric method (Piepers et al. 2009a). Animals in supple-
mented and control groups did not differ significantly in
% blood and milk PMNL apoptosis at the time of enrolment.
However, in early lactation, substantial differences in both
blood and milk PMNL apoptosis were observed. In contrast
to similar trials in which the effect of other nutrients was
evaluated (Ceballos et al. 2009; Bouwstra et al. 2010),
supplementation was carried out at the individual cow level
rather than at the herd or a group level thereby avoiding the
introduction of ecological fallacy (Schukken et al. 1988).
This allowed us to precisely picture the relationship between
oral supplementation of MCFA and the blood and milk
PMNL viability over the dry period. Although interesting
statistically significant associations between MCFA supple-
mentation and both blood and milk PMNL apoptosis were
found, this obviously does not prove causality and basically
needs confirmation. Rather, the findings generate new
hypotheses on improving mammary gland immunity or
udder health around calving through nutrition and give
indications for future research.
MCFA are composed of six (C6H12O2, caproic acid),
eight (C8H16O2, caprylic acid), ten (C10H20O2, capric acid),
twelve (C12H24O2, lauric acid) or fourteen (C14H28O2,
myristic) carbons and are derived from medium-chain tri-
glycerides which are well-known therapeutic fatty acids in
human medicine for the treatment of patients suffering from
malabsorption or malnutrition. MCFA passively diffuse from
the intestines to the hepatic portal vein without requiring any
modification like long-chain fatty acids or very-long-chain
fatty acids and thus no energy is needed for absorption,
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Fig. 2. (a) Back-transformed least square means of % apoptotic milk polymorphonuclear neutrophilic milk leucocytes (PMNLs) in both
control (■) and MCFA-supplemented ( ) animals between the start of supplementation (6–8 weeks before expected calving date) and early
lactation [1–3 d in milk (DIM)]. Significant pairwise differences (P<0·05) within and between treatment groups are indicated by a and b,
respectively. In control animals, % apoptotic milk PMNLs (6 multiparous cows) was significantly higher in early lactation than at dry-off.
Control animals had a significantly higher% apoptotic milk PMNLs (6 multiparous cows) in early lactation compared to the MCFA-
supplemented animals (6 multiparous cows). (b) Representative flow cytometric analysis of milk PMNLs with a dual colour Annexin-
V-fluorescein (FITC) and propidium iodide staining in control and MCFA-supplemented animals between the start of supplementation
(6–8 weeks before expected calving date) and early lactation [1–3 d in milk (DIM)]. The percentage of negative (=viable), single positive
(apoptotic) and double positive (=necrotic) PMNLs is shown in the individual quadrants.
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utilisation or storage (Bach & Barbayan, 1982). In cattle,
MCFA are particular renowned for their antimicrobial
activity against the rumenal microflora, influencing the
rumenal fermentation and thereby reducing the emission of
greenhouse gases such as methane which are partly
involved in the global warming process (Dohme et al.
2000, 2001). Caprylic acid possessed a bactericidal effect
in vitro against major mastitis pathogens (Nair et al. 2005).
Besides the microbicidal activity, there is in humans
increasing evidence that MCFA have immunomodulating
activities (Bellinati-Pires et al. 1993; Wanten et al. 2002;
Versleijen et al. 2005).
Apoptosis of bovine PMNL implies an impaired phago-
cytotic and oxidative burst activity (Van Oostveldt et al.
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Fig. 3. Back-transformed least square means of % apoptotic polymorphonuclear neutrophilic milk leucocytes (milk PMNLs) in both control
(■) and MCFA-supplemented ( ) animals in early lactation [1–3 d in milk (DIM)] for heifers and multiparous cows. Significant pairwise
differences (P<0·05) within and between treatment groups are indicated by a and b, respectively. Control animals (5 heifers and 6
multiparous cows) had a significantly higher % apoptotic milk PMNLs in early lactation compared to the MCFA-supplemented animals
(5 heifers and 6 multiparous cows), independently from their parity.
0
1
2
3
4
5
6
7
Ln
SC
C
Days in milk
1 - 3 14 - 45 46 - 75 76 - 105  106 - 135  
Fig. 4. Least square means (± SEM) of the natural logarithmic transformed composite somatic cell count (LnSCC) during the first 4 months of
lactation of medium-chain fatty acids (MCFA)-supplemented multiparous cows (○), non-supplemented multiparous cows (●), MCFA-
supplemented heifers (△) and non-supplemented heifers (▲). Multiparous cows had a significantly higher LnSCC than heifers. No significant
differences were observed between MCFA-supplemented animals and control animals.
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2002; Mehrzad et al. 2004) and has been associated with a
less proper host response to IMI (Mehrzad et al. 2004, 2005).
Determining the PMNL phagocytotic and oxidative burst
capacity itself might have given the results more strength.
Still, based on the findings of the above-mentioned studies
in which a very close relationship was observed between
PMNL apoptosis and oxidative burst activity, we were con-
fident that measuring PMNL apoptosis would allow us to get
a decent first indication of what potentially can be expected
from the oral supplementation of MCFA on the innate
immunity of dairy cows in early lactation.
Analogous to previous studies (Mehrzad et al. 2002;
Piepers et al. 2009b), PMNL apoptosis was much more pro-
nounced in milk than in blood. The latter finding can be
explained by the diapedesis of blood PMNL through the
blood-milk barrier and the ingestion of milk proteins and fat
globules once the PMNL have migrated into the mammary
gland. Both diapedesis through the blood–milk barrier and
ingestion of milk proteins and fat globules are known to
induce PMNL apoptosis (Van Oostveldt et al. 1999b; Paape
et al. 2003). Similar to the findings of Mehrzad et al. (2002) a
higher % apoptotic blood and milk PMNL was observed in
multiparous compared with primiparous cows. Decreased
PMNL viability and functionality around calving, as was
observed in the control animals in the present study, has
been thoroughly documented in literature as well (Guidry
et al. 1976; Kehrli et al. 1989; Van Oostveldt et al. 2001).
Cows that were orally supplementedwithMCFA appeared
to be protected against the drop in both blood and milk
PMNL viability during periparturient period as evidenced by
the stable % PMNL apoptosis in both blood and milk when
comparing start of supplementation and early lactation. In
non-supplemented controls, % blood PMNL apoptosis
significantly increased between start of supplementation
and the first days after calving whereas no substantial change
in%blood PMNL apoptosis could be observed in the supple-
mented animals. Additionally, % apoptotic milk PMNL in
early lactation was lower in supplemented animals com-
pared with control animals, independently of their parity.
Themechanisms bywhichMCFA could exert these potential
immunomodulating effects are yet not unravelled and are
basically beyond the scope of this study. Still, as this study is
in essence a hypotheses generating study, some hypotheses,
primarily derived from findings in human medicine litera-
ture, that might give perspectives for future research are put
forward. First, MCFA might involve a reduction of the nega-
tive effects of oxidative-stressed cows during transition.
Oxidative stress is the result of an imbalance between
increased production of reactive oxygen species (ROS)
causing cell and tissue damage and reduced availability of
antioxidants usually protecting cells from the damaging
effects of ROS. We previously found that supplementing
heifers with a commercial mineral/vitamin mix before
calving was associated with less blood and milk PMNL
apoptosis in early lactation. The latter finding was pre-
sumably related to higher concentrations of blood Se, a
well-known anti-oxidant (Piepers et al. 2009b). In rats
and humans, MCFA such as lauric acid seems to be able
to scavenge free radicals and thus are most likely to delay or
even prevent cell/tissue damage from oxidative stress (Henry
et al. 2002; Lemieux et al. 2011). Given the structure of
MCFA including a hydroxyl group MCFA could act as
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Fig. 5. Least square means (± SEM) of the average daily milk yield (MY) during the first 4 months of lactation of medium-chain fatty acids
(MCFA)-supplemented multiparous cows (○), non-supplemented multiparous cows (●), MCFA-supplemented heifers (△) and non-
supplemented heifers (▲). Test-day MY was significantly higher in multiparous cows than in heifers. Overall, no significant differences in
test-day MY were observed betweenMCFA-supplemented and control animals, although test-day MY at second test-day tended to be higher
in supplemented multiparous cows than in their non-supplemented counterparts (P=0·06).
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peroxyl radical scavengers in a similar way to vitamin E by
reacting with those radicals and by transferring themselves
into a MCFA-radical (MCFA-O) which could subsequently
be oxidised by a hydrogen donor such as vitamin C. Also, as
MCFA are fat-soluble and less prone to oxidation compared
with the poly-unsaturated fatty acids, they can be incorpor-
ated into cell membranes in similarity with humans, pro-
tecting them again from oxidative damage (Lemieux et al.
2008). The effect ofMCFA on the PMNL viability and activity
might also be mediated by G-protein coupled receptors
(Versleijen et al. 2009).G-proteins are a family of signal trans-
ducing proteins involved in transmitting chemical signals
outside the cell and causing changes inside the cell. Some
of those G-proteins are abundantly expressed in human
monocytes and PMNL and were shown to have MCFA as
ligands.Whether or not this kind of G-proteins are expressed
on the surface of bovine PMNL has yet not been investigated
and gives perspectives for further research. Clearly, these are
just some hypotheses derived from findings in humans and
rats; much more study is required to confirm and elucidate
the potential immunomodulating effects of MCFA on PMNL
viability in bovine and the underlying mechanisms behind
those effects.
Higher blood and milk PMNL viability is expected to
result in a more proper host response to IMI (Mehrzad et al.
2004). Consequently, fewer PMNLs will need to be recruited
which one would anticipate to result in less tissue damage
and lower milk production losses. Still, in this study, oral
supplementation of MCFA throughout the dry period and in
the first months after calving did neither substantially affect
the likelihood of IMI in early lactation nor the composite
milk SCC and test-day MY throughout the first 4 months after
calving. OneMCFA-supplemented coweven suffered from a
very severe case of clinical mastitis 5 d before calving. No
antimicrobial activity in vivo of the oral MCFA supplemen-
tation was expected as Grummer & Socha (1989) only found
negligible changes in the milk fat composition after oral
supplementation of medium chain triglycerides in dairy
cows. As MCFA are directly absorbed via the hepatic portal
vein, the efficiency of transfer of absorbedMCFA to milk was
expected to be low due to extensive oxidation in the liver
(Bach & Barbayan, 1982). The discrepancy between the
positive effect of MCFA supplementation on % blood and
milk PMNL apoptosis and the lack of effect on the likelihood
for IMI and test-day SCC might be explained by the fact that
the risk for IMI and thus an increased SCC is still determined
by a balance between the number of bacteria the cow is
exposed to and the cow’s immune response. Although the
role of the cow’s immune response might not be under-
estimated, the number of bacteria the cow is exposed to
is most likely still of overriding importance in the establish-
ment of IMI. If cows are exposed to a high number of
pathogenic bacteria, there is a very high chance that they
will contract an IMI and thus suffer from an increased test-
day SCC, independently from their immune status. Farms
with a BMSCC>250000 cells/ml probably have less optimal
hygienic conditions, thereby maintaining a high level of
bacteria in the environment (Barkema et al. 1999). The high
number of bacteria the cows were exposed to during the
dry period and thereafter might, hypothetically, have
outweighed the positive effect of a lower proportion of
apoptotic PMNL in the supplemented group compared with
the control group on the susceptibility for new IMI in this
study. On the other hand, there is increasing evidence from
human medicine that MCFA might stimulate the PMNL in a
way that they are already exhausted at the time they have
contact with pathogens (i.e. probably due to phagocytosis
of fat particles) which might, in turn, result in an impaired
cellular immune response and hence in a potentially
increased risk for either IMI or a more severe inflammatory
reaction (Bellinati-Pires et al. 1993; Versleijen et al. 2005).
Although no overall effect on the test-day MY was observed
and that the supplemented animals had a somewhat higher
test-day SCC than the control ones, test-dayMY tended to be
higher in the supplemented multiparous cows than in their
control counterparts at second test-day. Still, evaluation of
the oral supplementation of MCFA on the test-day SCC and
MY throughout lactation was not themain focus of this rather
small-scale explorative clinical trial. Until more thorough
research on the effect of MCFA-supplementation and cow
performance throughout lactation including more animals
on farms with different management styles has been con-
ducted, care should be taken in the interpretation of these
data and in drawing conclusions herein.
Conclusions
Oral supplementation of MCFA to heifers and multiparous
cows from 6–8 weeks before calving significantly sup-
pressed the physiological drop in blood and milk PMNL
viability in the first days after calving in both heifers and
older cows.Oral supplementation ofMCFA could, therefore,
offer an opportunity to stimulate the cellular immunity and
support the cows in meeting their everyday challenges,
particularly in the critical period around calving. Although
the results seem to be very promising, this was only a first
explorative and hypothesis generating study on the immuno-
modulating effect of MCFA in periparturient dairy cows and
thus further research is needed to confirm the findings and
scrutinise the underlying mechanisms. Also, multiparous
cowsmight benefit from oral MCFA-supplementation during
dry period and in the first months thereafter in the form of
increased milk productions at peak lactation although a
study including more animals is needed to come to better
conclusions.
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